Sarah-Maria Fendt and Markus Ralser awarded EMBO Gold Medal 2020
This year’s EMBO Gold Medal is going to two researchers who study cell metabolism, Sarah-Maria Fendt and Markus Ralser.
EMBOEncounters:
Biannual EMBO magazine
EMBO newsletters
- Contact
EMBO Communications
You are here:
Category: Press releases
“Mini brain” organoids show potential for SARS-CoV2 to cause neurodegenerative- disease-like effects
New research published yesterday in The EMBO Journal reports that the SARS-CoV-2 coronavirus can target human neurons with the potential to cause disease of the central nervous system (CNS). The research showed that the virus can enter tiny laboratory-developed 3D structures called brain organoids that replicate key aspects of the human brain and induce pathological effects similar to early stages of diseases of the CNS such as Alzheimer’s.
Naturally occurring antibodies against prion proteins found in humans
Antibodies targeting the normal PrP version of the prion protein have been found in humans selected at random with no history of any associated transmissible spongiform encephalopathies.
EMBO announces newest elected members
EMBO has bestowed upon 63 leading scientists the lifetime honour of EMBO Membership in recognition of their remarkable achievements in the life sciences, it was announced today.
New EMBO Fellowships for Core Facility staff
EMBO announces an extension of its current Short-Term Fellowship scheme: Core Facility Fellowships. These fellowships will support exchanges of technology and expertise between core research facilities that provide services to research institutions or universities.
Elly Tanaka receives the FEBS | EMBO Women in Science Award 2020
EMBO and FEBS announce Elly Tanaka of the Research Institute of Molecular Pathology, Vienna BioCenter, Austria, as the recipient of the FEBS | EMBO Women in Science Award 2020.
Eleven researchers receive EMBO Installation Grants to establish independent laboratories
EMBO is pleased to announce that eleven life scientists have been selected to receive Installation Grants, which will support them in establishing independent laboratories in the Czech Republic, Poland, Portugal and Turkey.
Review Commons, a pre-journal portable review platform
Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
EMBO welcomes first Global Investigators
Nine life scientists join the new EMBO Programme in its first year
Exploring drug repurposing to treat glioblastoma
MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.